C'bon Cosmetics Co.,Ltd.

TSE:4926.T

1202 (JPY) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2023202220212020201920182017201620152014201320122011201020092008
Revenue 8,498.9738,525.4289,153.4739,101.9311,101.79912,541.30912,564.67112,493.30712,833.42113,934.88415,017.62614,147.89914,228.15714,639.36614,936.14914,305.158
Cost of Revenue 2,099.0182,186.1812,049.6742,180.8582,522.5112,827.862,573.3152,550.2312,628.8282,884.5152,757.0312,743.5342,725.8982,654.2262,812.2172,627.842
Gross Profit 6,399.9556,339.2477,103.7996,921.0728,579.2889,713.4499,991.3569,943.07610,204.59311,050.36912,260.59511,404.36511,502.25911,985.1412,123.93211,677.316
Gross Profit Ratio 0.7530.7440.7760.760.7730.7750.7950.7960.7950.7930.8160.8060.8080.8190.8120.816
Reseach & Development Expenses 159.251160170187230209191.239200.539197.085200.09162.101129.457109.515124.514124.752113.13
General & Administrative Expenses 000000469.361649.982745.142803.795818.7191,377.1311,322.8421,402.5991,404.9311,341.381
Selling & Marketing Expenses 0000001,526.631,525.6881,633.0841,856.9762,053.9191,984.2111,650.4871,647.4331,683.2811,707.434
SG&A 6,211.3046,4846,9107,8248,8979,4611,995.9912,175.672,378.2262,660.7712,872.6383,361.3422,973.3293,050.0323,088.2123,048.815
Other Expenses -1.4712.72103.89388.23142.12137.4657,232.02443.92448.3354.10253.73746.12826.20952.98726.08953.568
Operating Expenses 6,370.5556,484.56,910.0927,824.8228,897.5549,461.759,419.2548,065.2968,385.1548,919.0649,344.9219,652.1539,292.279,799.5819,954.3649,596.718
Operating Income 29.4-145.253193.706-903.749-318.266251.698572.094325.328235.063539.7151,370.399876.9541,394.5441,343.9631,368.4131,196.995
Operating Income Ratio 0.003-0.0170.021-0.099-0.0290.020.0460.0260.0180.0390.0910.0620.0980.0920.0920.084
Total Other Income Expenses Net -3.584-219-90335-3144362.268-1,623.62-1,561.904-1,544.408-1,472.861-870.892-1,606.619-960.841-776.367-989.081
Income Before Tax 25.816-364.23104.906-569.52-632.474295.985634.362254.16257.535586.8971,442.813881.32603.371,224.7181,393.2011,091.517
Income Before Tax Ratio 0.003-0.0430.011-0.063-0.0570.0240.050.020.020.0420.0960.0620.0420.0840.0930.076
Income Tax Expense 52.16457.53860.03452.352437.601156.327249.72377.886153.083284.499602.664388.167343.949549.748559.182558.511
Net Income -26.348-421.76844.872-621.872-1,070.075139.657384.639176.273104.452302.398840.149493.153259.421674.969834.018533.005
Net Income Ratio -0.003-0.0490.005-0.068-0.0960.0110.0310.0140.0080.0220.0560.0350.0180.0460.0560.037
EPS -6.16-98.5310.48-145.27-250.0233.8193.9343.1425.8375.51206.73120.4661.14159.08196.561,256.2
EPS Diluted -6.16-98.5310.48-145.27-250.0233.7393.6743.0825.7675.35206.46120.3661.14159.08196.561,256.2
EBITDA 171.847144.934526.003-285.93833.459599.139879.5893,860.1662,227.952,563.2853,269.52,104.0724,142.2292,561.792,524.372,474.578
EBITDA Ratio 0.020.0170.057-0.0310.0030.0480.070.3090.1740.1840.2180.1490.2910.1750.1690.173